Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
-
UN Global Compact CMO Forum Inspires Marketing Leaders to be Catalyst for Sustainability
-
Virginia Credit Union Receives $60,000 Financial Education Grant from National Credit Union Foundation
-
Results for the Period Ended 30 June 2024
-
Lingyun Xiang was appointed as a Cultural Exchange Ambassador for China and Chile by the Republic of Chile
-
Kronos Advanced Technologies Inc. and Yasheng Group Announce Key Milestone in Nuclear Battery Collaboration with Provisional Patent Filing
-
Oil-Dri Named One of the Top 100 Finalists for the 23rd Annual Chicago Innovation Awards
-
Canada Royal Milk hosts milestone event to celebrate Canada’s first infant formula manufacturing facility
-
Report in French
-
Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies
-
Davidson Kempner Capital Management LP : Form 8.3 - Smith (DS) plc
-
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
-
JOANN Kicks Off Holiday Season with Never-Before-Seen Savings Events to Encourage Customers to Make Blankets for Gifts and Giving
-
10 ARTS Foundation Announces Funding Awards for New York Film Academy (NYFA) Students and Alumni
-
Bank of America Named Best in Class in Javelin’s 2024 Cyber Trust in Banking Scorecard
-
Treat Your Family to Halloween Fun at Jellystone Park Camp-Resorts Nationwide
-
HTVRONT Is to Celebrate Its Fall Sale with up to 30% OFF
-
Edible Garden Announces Pricing of $5.65 Million Public Offering
-
Acuity Insights named one of Canada's Top Growing Companies by The Globe and Mail Report on Business
-
Acuity Insights named one of Canada's Top Growing Companies by The Globe and Mail Report on Business
-
Information on the shares issued by Rokiskio suris AB and the votes granted
-
BUYBACK OF RIKSBANK CERTIFICATES
-
Acceleration of EVIG’s European Rollout: Clean Motion and Valeo Deepen Collaboration at Valeo New Mobility Center in Amiens
-
Vow ASA: Notification of trade – primary insider
-
Rokiskio suris AB acquires own shares
-
CannabisNewsWire is a Gold Sponsor and Official NewsWire for the Grow Up Conference & Expo
-
Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD
-
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
-
Barrack, Rodos & Bacine Notifies Shareholders of Methode Electronics (MEI) of a Securities Class Action Lawsuit
-
Form 8.3 - Rightmove Plc
-
Qifu Technology Responds to Short Seller Report
-
Falcon Oil & Gas Ltd. - Notice of Special Meeting of Shareholders and Management Information Circular
-
Form 8.3 - Keywords Studios Plc
-
Falcon Oil & Gas Ltd. - Notice of Special Meeting of Shareholders and Management Information Circular
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Ensurge Micropower ASA - Registration of Share Capital Increase
-
Invesco Ltd: Form 8.3 - Rightmove PLC ;Public dealing disclosure
-
Form 8.3 - Keywords Studios plc - Octopus Investments
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
SYLA Reports First-Half 2024 Financial and Operational Results
-
Nadero Wealth Management Opens New Tax Consultancy in Jersey
-
Form 8.3 - AXA INVESTMENT MANAGERS: Segro plc
-
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Arbor Realty Trust (NYSE: ABR) Investors to Inquire About a Securities Fraud Class Action by September 30, 2024
-
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
-
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
-
Hammond Power Solutions Closes $65.5 Million Bought Deal Secondary Offering
-
Late-Breaking Data at EADV of ESK-001, an Oral TYK2 Inhibitor for the Treatment of Psoriasis, Demonstrate Significant Responses with Sustained Increases Over 28 Weeks in Phase 2 OLE Study
-
Turning Point of Tampa Now In-Network with Blue Cross Blue Shield Insurance
